Bullish Palantir Article Clashes with DeepValue's Cautious Wait-and-See Stance

What happened

A Seeking Alpha article published on March 26, 2026, promotes a Strong Buy rating for Palantir, emphasizing accelerating revenue, elite margins, and a fortress balance sheet with $7.2B cash, while highlighting U.S. commercial growth at 137% YoY and government expansion prospects. However, the latest DeepValue master report maintains a 'WAIT' rating, noting that the stock at $137.19 already prices in aggressive FY2026 revenue growth of ~61% YoY and sustained AIP-led deal conversion. Critical to the investment case is verifying whether Q4 2025's commercial TCV of ~$2.6B and 61 deals worth $10M+ represent a repeatable run-rate or a one-time pull-forward, with the next 1-2 quarters serving as key tests. Valuation remains a major concern, with P/E at 202x and EV/EBITDA at 218x offering no margin of safety, meaning any shortfall in commercial TCV or RPO conversion timing could trigger significant downside. Thus, investors must look beyond optimistic headlines and focus on concrete data in upcoming earnings to assess if Palantir's growth narrative holds up against high expectations.

Implication

Palantir's current stock price embeds flawless execution of aggressive growth targets, leaving no cushion for disappointment in key metrics like commercial TCV and RPO conversion. The company must demonstrate that Q4 2025's booking surge wasn't anomalous by keeping commercial TCV consistently above $2.0B per quarter and $10M+ deal counts near 61 to validate AIP's repeatability. Additionally, RPO conversion timing needs to adhere to the disclosed schedule (~38% in 12 months) to prevent revenue misses and maintain investor confidence in backlog visibility. Government opportunities, such as the Army framework up to $10B, require translation into funded task orders to prove durability beyond headline contracts. Without clear confirmation in the next 3-6 months, the risk of multiple compression from lofty valuations outweighs potential upside, making patience prudent.

Thesis delta

The Seeking Alpha article amplifies the bullish narrative but does not materially shift the core thesis from DeepValue, which remains a 'WAIT' rating due to valuation concerns and unverified growth sustainability. The investment case still hinges on upcoming quarterly data showing commercial TCV above $2.0B per quarter and stable $10M+ deal counts to confirm AIP's scalability. No change in stance is justified until actual performance metrics align with optimistic projections, as the high multiples leave no room for error.